FIIs are leaving Adani Enterprises. Here’s who is buying
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Profit by knowlytics
Uncover the latest corporate headlines, economic policies, macro-level market updates, and industry developments shaping Indian and global markets on FinSiddhi.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
America’s biggest technology companies are beginning to generate meaningful AI-driven revenue, but surging infrastructure spending is putting free cash flow under pressure. Reuters’ analysis of LSEG estimates shows capital expenditure is expected to outpace free cash flow by 2027, shifting investor focus toward AI monetisation and long-term returns.
European stocks edged lower on Wednesday as technology shares declined ahead of earnings from Alphabet and Tesla, while investors monitored escalating geopolitical tensions in the Middle East. Energy stocks outperformed on higher oil prices, with markets also reacting to corporate earnings from Santander and Hiab.
Britain’s annual consumer price inflation eased to 2.6% in June from 2.8% in May, coming in below expectations as energy prices moderated. While the slowdown offers relief for policymakers and markets, inflation remains above the Bank of England’s target, keeping future interest rate decisions firmly in focus.
Adani Green Q1 Results: Adani Green reported a 19% year-on-year profit increase in the first quarter. Revenue from operations grew sixteen percent, driven by capacity expansion and strong performance. The company’s operational capacity rose twenty-seven percent to over twenty gigawatts. Energy sales increased thirty percent, aided by fresh greenfield capacity additions. Adani Green is progressing…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Several midcap stocks have witnessed sharp corrections despite the index gains. We highlight 14 such stocks that have fallen 15-50% over the past six months.
Donald Trump’s announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analysts believe the long-term impact could be limited, citing India’s manufacturing cost advantage, US-based production facilities of several drugmakers and uncertainty over how and when the tariffs will be implemented.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…